ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0677

Pro-Inflammatory Diet and Increased Risk of Incident Female Gout: 30-Year Prospective Cohort Study of >170,000 Pre- and Post-Menopausal US Women

Natalie McCormick1, Chio Yokose2, Na Lu3, Amit Joshi1 and Hyon K. Choi4, 1Massachusetts General Hospital, Boston, MA, 2Massachusetts General Hospital, Waltham, MA, 3Arthritis Research Canada, Vancouver, BC, Canada, 4Massachusetts General Hospital, Lexington, MA

Meeting: ACR Convergence 2021

Keywords: diet, gender, gout, Inflammation, risk factors

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Metabolic & Crystal Arthropathies – Basic & Clinical Science Poster I (0660–0682)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Globally, the prevalence of gout is rising in females more than males,1 but data on modifiable risk factors for female gout are scarce. Emerging evidence suggests inflammation may drive the progression from hyperuricemia to clinical gout,2 but the role of extrinsic, modifiable sources of chronic inflammation on gout risk, such as diet, is unknown. Greater dietary inflammatory potential has been independently associated with increased risk of incident cardiovascular disease (CVD)3 and type 2 diabetes (T2D),4 conditions with higher prevalences among females with gout. We prospectively examined the relation between dietary inflammatory potential and gout risk in two large cohorts of US women over 30 years.

Methods: We studied 77,425 women from Nurses Health Study (NHS) (1986-2016) and 93,454 from NHS II (1989-2017) who were free of gout at baseline. Dietary intake and covariates were ascertained by validated questionnaires every 2-4 years, along with new cases of physician-diagnosed gout (every 2 years). Inflammatory potential of diet was evaluated using a food-based, empirical dietary index of inflammatory potential score (EDIP), pre-defined based on circulating levels of IL-6, C-reactive protein, adiponectin, and TNFαR2.5

We assigned an EDIP score for each woman, adjusted for total energy intake, and used Cox proportional hazards models to prospectively examine the relation between quintiles of cumulative average EDIP scores (reflection of habitual diet) and incident gout, adjusting for potential confounders. We further adjusted for body mass index (BMI), a potential causal intermediate, and conducted subgroup analyses.

Results: We documented 5,283 cases of incident gout over 4,317,270 person-years, including 3,670 in the NHS (mean age of 50 years at baseline; 49% post-menopausal) and 1,613 in NHS II (mean age 36 years; 3.6% post-menopausal). In pooled multivariable-adjusted (MV) analyses, women in the highest EDIP quintile had nearly two-times greater risk of gout (MV HR 1.9, 95% CI: 1.7 to 2.1) compared to women in the lowest quintile (Table 1). This remained positive with further adjustment for BMI, a likely causal intermediate (MV HR 1.5, 95% CI 1.4 to 1.7).

Effects were similar for the older and younger cohorts, with MV HRs of 1.9 (95% CI 1.7 to 2.1, p for trend < 0.001) and 1.9 (1.6 to 2.2, p < 0.001) before BMI adjustment, in the NHS I and II, respectively, and 1.6 (1.4 to 1.7, p < 0.001) and 1.5 (1.3 to 1.8, p < 0.001), respectively, after BMI adjustment. Estimates did not differ significantly across other subgroups.

Conclusion: In these large prospective cohorts of both older and younger women, habitual pro-inflammatory dietary pattern was independently associated with increased risk of incident gout, beyond the pathway through adiposity. Our findings support a role for chronic inflammation in development of female gout, similar to CVD1 and T2D.2 Adhering to a diet with lower inflammatory potential may modulate systemic and metabolic inflammation, potentially reducing gout risk and these life-threatening comorbidities among women.

1Shen Arthrit Rheum (2021); PMID 33760368
2Xia Rheumatology (2020); PMID 31624843
3Li JACC (2020); PMID 32406924<
4Lee Diabetes Care (2020); PMID 32873589
5Tabung; PMID 27358416

Table 1: Hazard Ratio (HR) of Incident Gout According to Quintiles of Inflammatory Diet Score

Table 2: Hazard Ratio (HR) of Incident Gout According to Quintiles of Inflammatory Diet Score, by subgroups


Disclosures: N. McCormick, None; C. Yokose, None; N. Lu, None; A. Joshi, None; H. Choi, None.

To cite this abstract in AMA style:

McCormick N, Yokose C, Lu N, Joshi A, Choi H. Pro-Inflammatory Diet and Increased Risk of Incident Female Gout: 30-Year Prospective Cohort Study of >170,000 Pre- and Post-Menopausal US Women [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/pro-inflammatory-diet-and-increased-risk-of-incident-female-gout-30-year-prospective-cohort-study-of-170000-pre-and-post-menopausal-us-women/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pro-inflammatory-diet-and-increased-risk-of-incident-female-gout-30-year-prospective-cohort-study-of-170000-pre-and-post-menopausal-us-women/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology